• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2018.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Israeli Company Set To Begin Testing New Radiation Cancer Therapy
    November 26, 2018
    Israeli optimized therapeutics co PolyPid raises USD 15m
    November 8, 2018
    Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer C
    November 7, 2018
    Mapi Pharma raises USD 10m from Chinese investor
    November 5, 2018
    Anchiano Therapeutics files for USD 30-40m Nasdaq offering
    November 1, 2018
    Shavit Completes USD 100m Investment Round for Its Fifth Fund
    October 31, 2018
    Intec Completes Enrollment of Phase 3
    October 22, 2018
    PolyPid Begins Phase 2 Study in Prevention of Abdominal Surgical Site Infecti
    October 15, 2018
    Mapi Presents Phase II Extension Results of GA Depot
    October 9, 2018
    Gamida Cell to raise USD 69m in Nasdaq IPO
    October 2, 2018